Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Control Groups × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

OTHER 7 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6 Gastrointestinal 3 Other hematologic neoplasm 1 Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

fludarabine 5 Cyclophosphamide 5 Azacitidine 4 Cytarabine 3 venetoclax 2 pegylated granulocyte colony-stimulating factor 2 Metformin 2 Etoposide 2 Dasatinib 2 Clofarabine 2 Busulfan 2 vosaroxin 1 treosulfan 1 peginterferon alfa-2a 1 nilotinib 1 liposomal amphotericin B 1 fludarabine phosphate 1 defactinib 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 cc-486 1 bisantrene 1 aldesleukin 1 Zinc Sulfate 1 Zinc 1 Vitamin D 1 Urination 1 Tranexamic Acid 1 Thiotepa 1 Thalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04240600 2020-09-03

HEMVEF

Hospital General de Mexico

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡